| Greenley Primary Care | |
|
19747 Greenley Rd Suite S-2 Sonora CA 95370-5998 | |
| (209) 536-2665 | |
| (209) 533-7696 |
| Full Name | Greenley Primary Care |
|---|---|
| Speciality | Family Medicine |
| Location | 19747 Greenley Rd, Sonora, California |
| Authorized Official Name and Position | Andrew D. Jahn (CEO) |
| Authorized Official Contact | 2095365011 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Greenley Primary Care 14542 Lolly Ln Sonora CA 95370-9226 Ph: (209) 536-3900 | Greenley Primary Care 19747 Greenley Rd Suite S-2 Sonora CA 95370-5998 Ph: (209) 536-2665 |
| NPI Number | 1033100854 |
|---|---|
| Provider Enumeration Date | 11/01/2005 |
| Last Update Date | 09/28/2016 |
| Medicare PECOS PAC ID | 4284538505 |
|---|---|
| Medicare Enrollment ID | O20040316000829 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033100854 | NPI | - | NPPES |
| ZZZ52953Z | Other | CA | BLUE CROSS/BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 030000094 (California) | Primary |
| Provider Name | Felix Anthony Conte |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1285712760 PECOS PAC ID: 7719872365 Enrollment ID: I20040220000965 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Donald K Westbie |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1912984436 PECOS PAC ID: 7416940135 Enrollment ID: I20040407000516 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Sarah Margaret Grimes |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1922037563 PECOS PAC ID: 2264418706 Enrollment ID: I20040625000895 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Mark P Miller |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1073575353 PECOS PAC ID: 7214916295 Enrollment ID: I20040715001396 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Devanie S Teel |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1861584823 PECOS PAC ID: 5092785949 Enrollment ID: I20040728000693 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Christopher J Krpan |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1811059918 PECOS PAC ID: 1951374396 Enrollment ID: I20040823001068 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Stephen J Hopkins |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1265498539 PECOS PAC ID: 5294797569 Enrollment ID: I20041028001148 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Liliana Gelvez |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1205972957 PECOS PAC ID: 6204892318 Enrollment ID: I20041209000394 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | James L Reese |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1538173059 PECOS PAC ID: 9436116357 Enrollment ID: I20041213000646 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Julia A Gustafson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174509103 PECOS PAC ID: 1254388804 Enrollment ID: I20050405001299 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Deborah Leanne Kagay |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700098597 PECOS PAC ID: 5395786495 Enrollment ID: I20050519000114 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Jennifer L Neufeld Trujillo |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1861482671 PECOS PAC ID: 0244266641 Enrollment ID: I20050715000831 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Karen A Reardon |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1013095827 PECOS PAC ID: 8921023706 Enrollment ID: I20051011000443 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Claudia D Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780734632 PECOS PAC ID: 1052325875 Enrollment ID: I20060201000275 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Sean Anderson |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1144287061 PECOS PAC ID: 0547263295 Enrollment ID: I20060817000564 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Gilbert Simoni |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1316922958 PECOS PAC ID: 7315970787 Enrollment ID: I20061120000297 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Kenneth M Royle |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1891873378 PECOS PAC ID: 6406845395 Enrollment ID: I20070626000799 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Jenna Johnson |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1710969191 PECOS PAC ID: 7618059940 Enrollment ID: I20080125000376 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Matthew L Personius |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1528022712 PECOS PAC ID: 9931195328 Enrollment ID: I20080425000402 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Ayman A Hosny |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1265414155 PECOS PAC ID: 3870675671 Enrollment ID: I20080521000408 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Ralph Retherford |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801043799 PECOS PAC ID: 5496820862 Enrollment ID: I20080819000856 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Kishore K Kalluri |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1073517751 PECOS PAC ID: 3476574732 Enrollment ID: I20081216000355 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Steven E Shield |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1619954237 PECOS PAC ID: 1153484837 Enrollment ID: I20090106000675 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Alberto A Bolanos |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1467548008 PECOS PAC ID: 6406919745 Enrollment ID: I20090113000075 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Charles G Cox |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1760467443 PECOS PAC ID: 5092888685 Enrollment ID: I20090303000447 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Tanja S Frey |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1124178884 PECOS PAC ID: 9638236540 Enrollment ID: I20090320000200 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Matthew T Maynard |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1861617417 PECOS PAC ID: 0941391056 Enrollment ID: I20091211000329 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Renee H Kramer |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1558584466 PECOS PAC ID: 9032393301 Enrollment ID: I20110411000675 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Sundararajan Srikanth |
|---|---|
| Provider Type | Practitioner - Interventional Cardiology |
| Provider Identifiers | NPI Number: 1104934082 PECOS PAC ID: 0042497414 Enrollment ID: I20110613000239 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Jacey Jean Rodriguez-serva |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215255062 PECOS PAC ID: 6608046149 Enrollment ID: I20110819000230 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Sapoora Manshaii |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1922041185 PECOS PAC ID: 4587564174 Enrollment ID: I20111221000399 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Randolph B Roxas |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1174560072 PECOS PAC ID: 9234305145 Enrollment ID: I20111227000322 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Wais Tarrar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801047998 PECOS PAC ID: 2264619709 Enrollment ID: I20120604000080 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Airell L Nygaard |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1417920760 PECOS PAC ID: 3870499304 Enrollment ID: I20120703000593 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | John P Nelligan |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1952491151 PECOS PAC ID: 1759310279 Enrollment ID: I20120827000636 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Theodore N Powers |
|---|---|
| Provider Type | Practitioner - Anesthesiology |
| Provider Identifiers | NPI Number: 1740417187 PECOS PAC ID: 5597914523 Enrollment ID: I20121005000385 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Sekhar Ujwala U Eadula |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1427313345 PECOS PAC ID: 7719131416 Enrollment ID: I20130205000341 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Suzanne E Spillner |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316211576 PECOS PAC ID: 8325286131 Enrollment ID: I20130605000586 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Michael Salvatore Nuzzo |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1265583587 PECOS PAC ID: 4284792193 Enrollment ID: I20130622000119 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Kelley W George |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1396721171 PECOS PAC ID: 8325288517 Enrollment ID: I20130711000635 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Rhunjay J Yu |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1255527024 PECOS PAC ID: 7719113745 Enrollment ID: I20131122000781 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Mathea J Salas |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1184781932 PECOS PAC ID: 7810953759 Enrollment ID: I20140821000801 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Christopher L Jones |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1649594417 PECOS PAC ID: 8123249703 Enrollment ID: I20141023001998 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Krysta L Wolken |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1073914347 PECOS PAC ID: 1153644133 Enrollment ID: I20141223001945 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Janet J Briggs |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1225323165 PECOS PAC ID: 2062735871 Enrollment ID: I20150101000017 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Loretta M Obrien |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1750379657 PECOS PAC ID: 5092965798 Enrollment ID: I20150529002321 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Chrystal A L Bradley |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1366886392 PECOS PAC ID: 2961718176 Enrollment ID: I20150902003131 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Nathaniel Methot |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225422140 PECOS PAC ID: 6103121983 Enrollment ID: I20160217000772 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Daniel Su |
|---|---|
| Provider Type | Practitioner - Urology |
| Provider Identifiers | NPI Number: 1235442534 PECOS PAC ID: 1052548013 Enrollment ID: I20161219002099 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Guiqing Huang |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1710364856 PECOS PAC ID: 3971884040 Enrollment ID: I20170103001761 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Cynthia N Carbin |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1376609008 PECOS PAC ID: 8527159110 Enrollment ID: I20170327002433 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Anna Khananian |
|---|---|
| Provider Type | Practitioner - Rheumatology |
| Provider Identifiers | NPI Number: 1982137287 PECOS PAC ID: 6800167388 Enrollment ID: I20170801003139 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Neal K Kaushal |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1447542238 PECOS PAC ID: 0547534679 Enrollment ID: I20170927003861 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Michael Richard Portillo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1306235957 PECOS PAC ID: 4981961265 Enrollment ID: I20171121001297 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Megan Mary Greenberg |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1740623420 PECOS PAC ID: 6800167990 Enrollment ID: I20171130000816 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Carlos Alvarez |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1982679239 PECOS PAC ID: 5193799161 Enrollment ID: I20180808002455 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Erica M Vega |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1316367469 PECOS PAC ID: 1153672126 Enrollment ID: I20181002000757 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Jacob L Wester |
|---|---|
| Provider Type | Practitioner - Otolaryngology |
| Provider Identifiers | NPI Number: 1447693973 PECOS PAC ID: 2062764962 Enrollment ID: I20181003003042 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Cicely Chen |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1043625916 PECOS PAC ID: 3375897077 Enrollment ID: I20181115002381 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Robert B Hoffman |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1437145380 PECOS PAC ID: 4688827868 Enrollment ID: I20181128000693 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Sheila K Ponzio |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1992742381 PECOS PAC ID: 7719145473 Enrollment ID: I20190227001774 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | David F Bohannon |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1881072643 PECOS PAC ID: 7012248693 Enrollment ID: I20191011002334 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Anne L Palumbo |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1396731709 PECOS PAC ID: 3870536600 Enrollment ID: I20191219002052 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Jocelyn Moll |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1285090902 PECOS PAC ID: 8729382742 Enrollment ID: I20200108000289 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | William G Stone |
|---|---|
| Provider Type | Practitioner - General Surgery |
| Provider Identifiers | NPI Number: 1255505764 PECOS PAC ID: 5395992960 Enrollment ID: I20200420000194 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Sanya M Wadhwa |
|---|---|
| Provider Type | Practitioner - Gastroenterology |
| Provider Identifiers | NPI Number: 1003234501 PECOS PAC ID: 5092088369 Enrollment ID: I20200630002375 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Yewande Adeshina |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1346334596 PECOS PAC ID: 4880696582 Enrollment ID: I20200805001425 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Alexa L Calfee |
|---|---|
| Provider Type | Practitioner - Obstetrics/gynecology |
| Provider Identifiers | NPI Number: 1508108978 PECOS PAC ID: 4284052887 Enrollment ID: I20200914002779 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Matthew Narron |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1881831659 PECOS PAC ID: 6507271921 Enrollment ID: I20210217002042 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Hannah Cho Hyuna Row |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1427258243 PECOS PAC ID: 9931241783 Enrollment ID: I20210225002765 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Bethany J Bick |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1922504703 PECOS PAC ID: 5395090443 Enrollment ID: I20210525000922 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Ariana Abid |
|---|---|
| Provider Type | Practitioner - Addiction Medicine |
| Provider Identifiers | NPI Number: 1285154807 PECOS PAC ID: 9931468584 Enrollment ID: I20210929001508 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Alexander C Heard |
|---|---|
| Provider Type | Practitioner - Pediatric Medicine |
| Provider Identifiers | NPI Number: 1316916471 PECOS PAC ID: 1658641261 Enrollment ID: I20211027002553 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | David Row |
|---|---|
| Provider Type | Practitioner - Colorectal Surgery (proctology) |
| Provider Identifiers | NPI Number: 1871797118 PECOS PAC ID: 9537212378 Enrollment ID: I20220224002207 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Norberto A Rodriguez |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1396706107 PECOS PAC ID: 9739224213 Enrollment ID: I20220311000646 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Manan A Jhaveri |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1306285739 PECOS PAC ID: 0941590152 Enrollment ID: I20220404002528 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Julia M Dean |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1932812138 PECOS PAC ID: 4880052463 Enrollment ID: I20230614003086 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Arnaldo Vivanco |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376034009 PECOS PAC ID: 2365804440 Enrollment ID: I20230822002012 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Seneca Ann Storm |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1285731588 PECOS PAC ID: 2961430160 Enrollment ID: I20230913002098 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Mohammad N Khan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295778215 PECOS PAC ID: 3476538760 Enrollment ID: I20230925001562 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | John Golden |
|---|---|
| Provider Type | Practitioner - Cardiovascular Disease (cardiology) |
| Provider Identifiers | NPI Number: 1780744268 PECOS PAC ID: 2567512973 Enrollment ID: I20240131000078 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
| Provider Name | Kristin B Toney |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1952853624 PECOS PAC ID: 4789964784 Enrollment ID: I20240229003242 |
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
News Archive
Their findings reveal that about 58% of all new coronavirus disease 2019 (COVID-19) cases are due to the delta variant and that the prevalence of vaccine breakthrough cases associated with the variant is as high as 20%. The study is currently available on the medRxiv* preprint server while awaiting peer review.
iMotions, a world leader in scalable Biometric Research solutions has partnered with Shimmer to release NeuroLab Computer, the latest ready-to-use solution available for research labs to conduct multimodal biometric research quickly and easily.
Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, announced today that the first patient has been enrolled in the CYPRESS study, which will assess clinical outcomes in a broad range of patients with coronary artery disease who take dual anti-platelet therapy after receiving a CYPHER Sirolimus-eluting Coronary Stent. The procedure was performed by Patrick Flaherty, D.O., Arkansas Heart Hospital in Little Rock, AK.
The president is having separate meetings with Democrats and Republicans from the House and Senate as both sides seek a solution to the impasse. Some Republicans are looking at a plan on entitlement changes from Rep. Paul Ryan as a roadmap, but others complain that he is abandoning the fight over the health law.
› Verified 5 days ago
Sonora Primary Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 13951 Mono Way, Suite A, Sonora, CA 95370 Phone: 209-532-3370 Fax: 209-532-3340 | |
Foothill Primary Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 650 Pauline Ct, Sonora, CA 95370 Phone: 209-532-5154 Fax: 209-533-7696 | |
Kathy Bosch Chiropractic, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 19515 Village Dr, Ste B, Sonora, CA 95370 Phone: 209-533-4330 Fax: 509-532-5374 | |
Sierra Elder Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 109 E Jackson St, Sonora, CA 95370 Phone: 209-454-7861 Fax: 209-288-2461 | |
William E. Zachow, D.o. Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 19747 Greenley Rd, Suite S-2, Sonora, CA 95370 Phone: 602-790-4221 | |
Sierra Gastroenterology Consultants Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 940 Sylva Ln, Bldg. B, Sonora, CA 95370 Phone: 209-532-7281 Fax: 209-532-7381 |